Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vet J ; 193(2): 381-5, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22266019

ABSTRACT

Equine piroplasmosis (EP) has not been considered indigenous in The Netherlands. However, following the detection of an apparently indigenous subclinical Babesia caballi infection in a horse on Schouwen-Duiveland (an island in the Zeeland Province), a survey was undertaken between May and September 2010 to assess the prevalence of the causative agents of EP in the South-West of The Netherlands. Blood samples from 300 randomly selected horses were tested for specific antibodies against Theileria equi and B. caballi using an indirect fluorescence antibody test (IFAT), and for parasite DNA using a specific polymerase chain reaction combined with reverse line blotting (PCR-RLB). Twelve of the horses (4%) were seropositive for EP. Of these, nine (75%) were positive (titre⩾1:160) for B. caballi alone and three (25%) were also positive for T. equi. PCR-RLB detected T. equi DNA in five horses (1.6%), two of which were seronegative. Four (1.3%) of the positive horses (three positive for T. equi and one for both B. caballi and T. equi) were considered truly indigenous. During the study, two indigenous ponies from a farm situated outside the sampling area were diagnosed with acute clinical piroplasmosis characterized by severe anaemia and pyrexia. Blood smears showed T. equi - like inclusions in red blood cells, and T. equi infection was confirmed in both ponies by PCR-RLB. The initial subclinical B. caballi infection, the survey results and the two acute clinical EP cases confirmed the autochthonous transmission of B. caballi and T. equi infections in The Netherlands.


Subject(s)
Babesia/isolation & purification , Babesiosis/veterinary , Horse Diseases/epidemiology , Theileria/isolation & purification , Theileriasis/epidemiology , Animals , Antibodies, Protozoan/blood , Asymptomatic Infections/epidemiology , Azure Stains/chemistry , Babesia/immunology , Babesiosis/blood , Babesiosis/epidemiology , Female , Fluorescent Antibody Technique, Indirect/veterinary , Horse Diseases/blood , Horses , Male , Netherlands/epidemiology , Polymerase Chain Reaction/veterinary , Prevalence , Seroepidemiologic Studies , Theileria/immunology , Theileriasis/blood
2.
Vet Immunol Immunopathol ; 97(1-2): 65-76, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14700538

ABSTRACT

Macrophages play a pivotal role in the pathophysiology of many diseases by mediating the host immune response to infections and intoxications. The species-specific activation of macrophages and the differential response in cytokine production impedes the extrapolation of results between species. Therefore, the aim of this study was to isolate and immortalise macrophages from equine bone marrow (BM) cells in order to study equine-specific signalling pathways. The isolated BM-derived macrophages (referred to as e-CAS cells) showed proliferation kinetics similar to that of standardised cell lines and were maintained in culture for >76 passages. To characterise the cells, a number of typical parameters of macrophages were tested. Morphological evaluation (May-Grünwald Giemsa staining) and non-specific esterase activity indicated the e-CAS cells to be macrophages. The presence of CD14 and their ability to phagocytose Escherichia coli bioparticles further confirmed their identity, as did their ability to produce cytokines, reactive oxygen and nitrogen intermediates in response to LPS. These data show that the established cell line (e-CAS) shows the characteristics of equine macrophages and may, therefore, prove to be a unique in vitro model for studying the cellular biology of equine inflammation.


Subject(s)
Bone Marrow Cells/cytology , Horses/immunology , Macrophages/cytology , Animals , Blotting, Western , Bone Marrow Cells/immunology , Bone Marrow Cells/metabolism , Bone Marrow Cells/virology , Cell Line , Female , Lipopolysaccharide Receptors/immunology , Macrophage Activation/immunology , Macrophages/immunology , Male , Nitric Oxide/biosynthesis , Nitric Oxide/immunology , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase/immunology , Nitric Oxide Synthase Type II , Phagocytosis/immunology , Reactive Oxygen Species/immunology , Reactive Oxygen Species/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...